STOCK TITAN
  1. Home
  2. BCEL

Atreca (BCEL) Stock Price, News & Analysis

BCEL OTC

Company Description

Atreca (OTC: BCEL) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for BCEL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
39.7M
Shares outstanding

Atreca (BCEL) stock last closed at $0.0900.

See what a $1,000 investment in BCEL would be worth today

Latest News

View All
-22.72%

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

-22.72%

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

acquisition
-23.01%

Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives

earnings
-1.24%

Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

-36.57%

Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring

earnings
+3.20%

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting

clinical trial

Atreca has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all BCEL news →

SEC Filings

View All

No SEC filings available for BCEL.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BCEL Company Profile & Sector Positioning

Atreca (BCEL) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of Atreca (BCEL)?

The current stock price of Atreca (BCEL) is $0.09 as of February 7, 2025.